Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urothelial Carcinoma of the Bladder × Proton Therapy × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 13 Prostate Adenocarcinoma 2 Wilms Tumor 1 Urothelial Carcinoma of the Bladder 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Radiation Injuries 1 Neoplasms 1 Glioma 1 Carcinoma, Hepatocellular 1

Interventions

Vinblastine 1 Transurethral Resection of Bladder 1 Radiotherapy, Intensity-Modulated 1 Proton Therapy 1 Mitomycin 1 Methotrexate 1 Fluorouracil 1 Doxorubicin 1 Cisplatin 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01520038 2019-11-26

Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer

Abramson Cancer Center at Penn Medicine

Phase 1/2 Completed

2 enrolled 12 charts

Urothelial Carcinoma of the Bladder

Data powered by HemOnc (CC BY 4.0) Colophon ⚡